Seguimiento de guías farmacoterapéuticas en mayores de 85 años con insuficiencia cardiaca estadio C. Efecto sobre la mortalidad al año

Treatment with CHF disease-modifying therapies except for spironolactone can reduce 12 month risk mortality, also in the oldest old. There exists room for improvement in frequency of drug prescription in this group of age.